Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination

Carcinogenesis

Volumn 31, Issue 9, 2010, Pages 1634-1641

  Kassie, Fekadu ^a,b   Melkamu, Tamene ^b   Endalew, Abaineh ^a   Upadhyaya, Pramod ^a   Luo, Xianghua ^a,c   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; CIGARETTE SMOKE CONDENSATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL (N 2 PHENETHYLTHIOCARBAMOYL)CYSTEINE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZO(A)PYRENE; BRONCHI; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYSTEINE; EPITHELIAL CELLS; FEMALE; HUMANS; INDOLES; INOSITOL; LUNG NEOPLASMS; MICE; MICE, INBRED A; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SMOKE; THIOCARBAMATES; VITAMIN B COMPLEX;

EID: 77956270068     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq139     Document Type: Article

References (49)

1. Jemal,A. et al. (2009) Cancer statistics, 2009. CA Cancer J Clin., 59, 225-249.
2. International Agency for Research on Cancer. (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83. IARC Press, Lyon, 53-119.
3. Tong,L. et al. (1996) Lung carcinoma in former smokers. Cancer, 78, 1004-1010.
4. Thompson,I.M. et al. (2003) The influence of finasteride on the development of prostate cancer. N. Engl. J. Med., 349, 215-224.
5. Meyskens,F.L. et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebocontrolled, double-blind trial. Cancer Prev. Res., 1, 32-38.
6. Kinsinger,L.S. et al. (2002) Chemoprevention of breast cancer: a summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med., 137, 59-69.
7. International Agency for Research on Cancer. (2004) Cruciferous vegetables, isothiocyanates and indoles. IARC Handbooks of Cancer Prevention. Vol. 9. IARC Printing Press, Lyon, 171-176.
8. Rahman,K.M. et al. (2006) Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol. Cancer Ther., 5, 2747-2756.
9. Kim,E.J. et al. (2009) Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J. Nutr., 139, 2373-2379.
10. Hwang,E.S. et al. (2006) Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells. Nutr. Biochem., 17, 837-846.
11. Jiao,D. et al. (1997) Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis. Carcinogenesis, 18, 2143-2147.
12. Bjeldanes,L.F. et al. (1991) Aromatic hydrocarbon receptor agonist generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA, 88, 9543-9547.
13. Lam,S. et al. (2006) A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiol. Biomarkers Prev., 15, 1526-1531.
14. Wattenberg,L.W. et al. (2000) Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis, 21, 179-182.
15. Estensen,R.D. et al. (1993) Studies of chemopreventive effects of myoinositol and benzo(a)pyrene induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis, 14, 1975-1977.
16. Hecht,S.S. et al. (2001) Dose-response study of myo-inositol as an inhibitor of lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett., 167, 1-6.
17. Kassie,F. et al. (2008) Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev. Res., 1, 568-576.
18. Han,W. et al. (2009) The chemopreventive agent myo-inositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. Cancer Prev. Res., 2, 370-376.
19. Hecht,S.S. et al. (2009) Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat. Rev. Cancer, 9, 476-488.
20. Mennicke,W.H. et al. (1983) Metabolism of some naturally occurring isothiocyanates in the rat. Xenobiotica, 13, 203-207.
21. Hecht,S.S. et al. (1983) Effects of-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis, 4, 305-310.
22. Kassie,F. et al. (2008) Combinations of N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice. Cancer Prev. Res., 1, 285-297.
23. Kassie,F. et al. (2009) Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice. Carcinogenesis, 31, 239-245.
24. Hecht,S.S. et al. (2002) Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination. Carcinogenesis, 23, 1455-1461.
25. Ji,Y. et al. (2003) Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatographytandem mass spectrometry. Anal. Biochem., 323, 39-47.
26. Reed,G.A. et al. (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3-diindolylmethane. Cancer Epidemiol. Biomarkers Prev., 15, 2477-2481.
27. Estensen,R.D. et al. (1993) Studies of chemopreventive effects of myoinositol on benzo(a)pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis, 14, 1975-1977.
28. Groenen,P.M. et al. (2003) Kinetics of myo-inositol loading in women of reproductive age. Ann. Clin. Biochem., 40, 79-85.
29. Hoffmann,D. et al. (1997) The changing cigarette, 1950-1995. J. Toxicol. Environ. Health, 50, 307-364.
30. Rodgman,A. et al. (2009) The Chemical Components of Tobacco Smoke. CRC press.
31. Brognard,J. et al. (2001) Akt/protein kinase b is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res., 61, 3986-3997.
32. Brognard,J. et al. (2002) Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ., 9, 893-904.
33. Tang,X. et al. (2006) Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer, 107, 2637-2646.
34. West,K.A. et al. (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest., 111, 81-90.
35. Laag,E. et al. (2006) NNK activates ERK1/2 and CREB/ATF-1 via b-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int. J. Cancer, 119, 1547-1552.
36. Tsao,A.S. et al. (2003) Increased phospho-AKT (Ser 473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol. Biomarkers Prev., 12, 660-664.
37. Balsara,B.R. et al. (2004) Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis, 25, 2053-2059.
38. Tsurutani,J. et al. (2005) Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis, 26, 1182-1195.
39. Vicent,S. et al. (2004) ERK1/2 is activated in non-small cell lung cancer and associated with advanced tumors. Br. J. Cancer, 90, 1047-1052.
40. Khan,N. et al. (2007) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res., 67, 3475-3482.
41. Stathopoulos,G.T. et al. (2007) Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc. Natl Acad. Sci. USA, 104, 18514-18519.
42. Agazie,Y. et al. (2002) Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene. Oncogene, 21, 697-707.
43. Zimmermann,S. et al. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science, 286, 1741-1744.
44. Burow,S. et al. (2000) PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem. Biophys. Res. Commun., 271, 342-345.
45. Yang,Y. et al. (2002) Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res., 62, 2-7.
46. Ye,B. et al. (2007) Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate. BMC Cancer, 7, 90.
47. Conaway,C.C. et al. (2005) Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res., 65, 8548-8557.
48. Kim,J. et al. (2006) Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with β-phenylethyl isothiocyanate and curcumin. Carcinogenesis, 27, 475-482.
49. Khor,T.O. et al. (2006) Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res., 66, 613-621.